Oxitec: Wins Best Emerging UK Synbio Company Award
October 02, 2015
Oxitec has been named the Best Emerging UK SynBio company by OBN for their pioneering work tackling insect pests that spread disease and damage crops. The award category recognizes the synthetic biology companies showing the greatest promise.
Hadyn Parry, CEO, said, “The health and food security challenges we are facing as a country and as a global society demand innovative solutions. We are grateful for the recognition that we are providing effective and environmentally friendly ways to control insect pests that are destroying important food crops and spreading terrible diseases like Dengue. By harnessing the potential of synthetic biology we are tackling these problems head on with the aim of improving lives around the world.”
Ross Sommerville, Interim CEO of OBN, said, “The UK life sciences sector is crucial for developing leading edge treatments for patients and is a vital part of the UK economy. Our Awards shine a light on the exciting and innovative achievements made throughout the past 15 months and in the long run will help maintain the industry’s prime position and ensure continued investment for new and emerging products.”
The 7th annual awards from OBN celebrate outstanding achievements in the UK life sciences from biotech, medtech, synbio, and investor companies, and were announced 1st October at the Ashmolean Museum in Oxford, UK.